Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Medicamen Biotech Limited
MEDICAMEQ | NSE
228.97
INR-2.67
-1.15%
MEDICAMEQ | NSE
Loading StockChartView...
About Medicamen Biotech Limited
Sector
Healthcare
Industry
Drug Manufacturers-Specialty & Generic
Earnings date
31/03/2024
As of date
02/04/2026
Close
228.97
Open
227.50
High
239.39
Low
225.01
Medicamen Biotech Limited researches develops manufactures sells and distributes pharmaceutical formulations and APIs in India. It offers a range of products including tablets such as non-beta lactum tablets; capsules comprising beta and non-beta lactum capsules; liquid and dry syrups; and ointments and creams. The company also provides lyohilized/dry powder injections and oral solid and liquid products. Its products are used in various therapeutic areas such as gastrointestinal pain management anti-infectives pediatrics dermatology gynecology and rheumatology diabetology cardiology oncology and the central nervous system. The company was incorporated in 1993 and is based in New Delhi India.
View LessMEDICAMEQ | NSE
Risk
43.6
Sharpe
-1.44
Luna's Score
39/100
Recommendation
Sell
Luna says (MEDICAMEQ | NSE)
What's Working
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
What's not Working
Negative Momentum (Declining Price)
Weakness based on declining price with high volume
Price Below SMA10D
High Short-term Volatility
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
Loading RiskMeterView...
10 days
60.7%1 month
43.6%3 months
46.8%6 months
44.8%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
82.74
Fwd. PE
-
Price to book
3.26
Debt to equity
0.15
Debt to assets
0.10
Ent. to EBITDA
28.30
Ent. to rev.
3.88
PEG
-
Other Fundamentals
EBITDA
188.65M
MarketCap
2.82B
MarketCap(USD)
30.35M
Div. yield
0.19
Op. margin
3.89
Erngs. growth
-79.80
Rev. growth
2.60
Ret. on equity
4.82
Short ratio
-
Short perc.
-
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
57.05
Range1M
92.80
Range3M
189.65
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
1.82
Price X volume
19.89M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 28.30 | 24.85 | Par |
| Ent. to Revenue | 3.88 | 11.40 | Cheaper |
| PE Ratio | 82.74 | 51.36 | Expensive |
| Price to Book | 3.26 | 6.83 | Cheaper |
| Dividend Yield | 0.19 | 0.52 | Poor |
| Std. Deviation (3M) | 46.85 | 42.17 | Par |
| Debt to Equity | 0.15 | 0.35 | Cheaper |
| Debt to Assets | 0.10 | 0.17 | Cheaper |
| Market Cap | 2.82B | 290.82B | Emerging |
